PHI-101 | FLT3 inhibitor | Probechem Biochemicals

Chemical Structure : PHI-101

Catalog No.: PC-24145Not For Human Use, Lab Use Only.

Lasmotinib (PHI-101) is a potent, selectivean orally bioavailable next-generation FLT3 inhibitor, overcomes secondary mutations.

Packing	Price	Stock	Quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote

Get Quotation Now

or Bulk Inquiry

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

Lasmotinib (PHI-101) is a potent, selectivean orally bioavailable next-generation FLT3 inhibitor, overcomes secondary mutations.

M.Wt	386.45
Formula	C19H19FN4O2S
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	(S)-5-((3-fluorophenyl)ethynyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide

1. Park SJ, et al. BMC Cancer. 2022 Jan 3;22(1):28.

2. Sung-Soo Yoon, et al. Blood (2023) 142 (Supplement 1): 4283.